Product Images Clopidogrel Bisulfate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Clopidogrel Bisulfate NDC 63187-639 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

figure1 - clopidogrel fig1

figure1 - clopidogrel fig1

This appears to be a chart displaying the effect of co-administered PPL on the active metabolite AUC for various drugs including Dexlansoprazole, Lansoprazole, Pantoprazole, and Omeprazole. The chart includes mean values and 90% confidence intervals. The numbers on the bottom likely represent time intervals or doses.*

figure3 - clopidogrel fig2

figure3 - clopidogrel fig2

The given text provides information on the cumulative event rate of cardiovascular death, myocardial infarction, and stroke. The event rate is presented as a percentage and is compared between two treatment options i.e. Placebo and Clopidogrel bisulfate- indicating the efficacy of each treatment in preventing the three fatal events. The data is further presented over a time period of several months with the use of other standard therapies.*

figure3 - clopidogrel fig3

figure3 - clopidogrel fig3

This appears to be a table showing the percentage of events related to different treatments or conditions. The table seems to show data related to different groups such as age range, race, and previous treatments. Specific information such as the number of events and percentage for each group is also included. There is mention of beta-blocker and an ACEL treatment, but it is unclear what these are referring to. A note at the bottom mentions the use of other standard therapies. Overall, without more context, it is difficult to interpret this data or provide a more precise description.*

figure4 - clopidogrel fig4

figure4 - clopidogrel fig4

This appears to be a table or a report related to a medical study. It includes data on the number of deaths and the percentage of deaths among patients taking Placebo and Cloptdogrel. The table shows that there were 1845 deaths (8.1%) in the Placebo group and 1726 deaths (75%) in the Cloptdogrel group. It also mentions a proportional risk reduction of 75% with a p-value of 0.03. The last row of the table shows the number of days since randomization, up to 25 days. It is unclear what the terms "e doad", "betoro", "tiet", and "discharge" represent.*

figure5 - clopidogrel fig5

figure5 - clopidogrel fig5

figure6 - clopidogrel fig6

figure6 - clopidogrel fig6

figure7 - clopidogrel fig7

figure7 - clopidogrel fig7

figure8 - clopidogrel fig8

figure8 - clopidogrel fig8

63187-639-30 - clopidogrel fig9

63187-639-30 - clopidogrel fig9

This is a description of Clopidogrel 75mg tablets from ScieGen Pharmaceuticals, Inc. They are pink, round, and biconvex with the letters SG and 124 on one side. Each tablet contains 97.875mg equivalent to 75mg of clopidogrel base. They come in a bottle of 30 tablets with the medication guide provided separately for each patient. The tablets are RX only and should be stored at 20°-25°C away from the children's reach. There are several lots with the same SN# MASTER and expiring on 00/00/00. The tablets have been relabeled by Proficient Rx LP in Thousand Oaks, CA.*

structure - clopidogrel str

structure - clopidogrel str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.